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hibition of late sodium current (INa, L) in a 2.5 year-old Chinese girl
with the typical TS phenotype of syndactyly, QT prolongation, 2:1 AV
block (AVB) and T wave alternans (TWA) in 2012. This study aimed to
review our practices over the past three years and promote the current
therapeutic strategies in the TS management.
METHODS Mexiletine (12.5 mg/kg per day) was initiated when the
proband’s 12-lead ECG revealed QTc of 600 ms, 2:1 AVB and TWA. 12-
lead ECGs and Holter monitoring were obtained once per month
during the ﬁrst year. Afterwards, Holter monitoring was performed
once in every 3-4 months. The QT interval was measured on lead II or
V5. Heart rate–corrected QT (QTc) was calculated using Bazett formula
(QT/ORR). The QT/RR slope was calculated based on the Holter
results.
RESULTS During the ﬁrst two years of treatment of mexiletine at a
maintenance dose of 150 to 200 mg daily, her ECGs and the Holter
monitoring revealed no 2:1 AVB and TWA, blunted QT/RR relationship
and QTc in a range from 500 to 560 ms. During this period, the patient
successfully underwent two syndactyly repair surgeries although the
anesthesiologist reported occurrence of one episode of non-sustained
polymorphic ventricular tachycardia during her second operation. In
the past one year, this patient had two episodes of syncope or
“seizure” activities. In one longer episode, she happened to wear a
Holter which did not reveal any ventricular arrhythmias. Although
they were not correlated to her syncope, 2:1 AVB and TWA reap-
peared. Her mexiletine dose was then adjusted to 250 mg daily. Dose
increase in mexiletine abolished 2:1 AVB and TWA.
CONCLUSIONS Our experiences suggests that inhibition of INa, L by
mexiletineis a promising pharmacotherapeutic approach in reduction
of arrhythmic risks in TS. However, mexiletine appears to lose its
efﬁcacy slowly with time.
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OBJECTIVES Three validated HAS-BLED, HEMORR2HAGES and
ATRIA bleeding scores, or even the CHADS2 and CHA2DS2-VASc stroke
scores, could be used to evaluate atrial ﬁbrillation(AF) patients’ major
bleeding risk. These scores have been validated in the various inde-
pendent studies. We therefore compared the diagnostic accuracy of
the HAS-BLED score to that of other risk scores in anticoagulated
patients with AF.
METHODS We systematically searched the Cochrane Library, Med-
line, PubMed and Embase databases for studies of the comparative
diagnostic performance between the HAS-BLED score and any of the
HEMORR2HAGES, ATRIA, CHADS2 or CHA2DS2-VASc scores. Data were
extracted from applicable studies, and then analyzed using statistical
methods such as the discrimination, calibration, net reclassiﬁcation
improvement(NRI) and integrated discrimination improvement(IDI)
analysis. The primary endpoints of AF patients were also deﬁned
dichotomously and compared between scores <3 and 3 for the HAS-
BLED score.
RESULTS 11 studies were identiﬁed for meta-analysis. We performed
the discrimination analysis by means of C-statistic with 95%
conﬁdence interval(CI). The pooled C-statistics respectively are
0.65(0.61-0.69) for HAS-BLED, 0.63(0.61-0.66) for HEMORR2HAGES,
0.63(0.56-0.72) for ATRIA, 0.55(0.49-0.61) for CHADS2 and 0.56(0.53-
0.59) for CHA2DS2-VASc. The HAS-BLED score demonstrates no sig-
niﬁcant differences of C-statistic for major bleeding risk prediction
when compared to the ATRIA or HEMORR2HAGES bleeding scores, but
gets the opposite results when compared to the CHADS2 or CHA2DS2-
VASc stroke scores. These results are further supported by the sig-
niﬁcant positive NRI and IDI values. Calibration analysis indicates the
HAS-BLED score over-predicts the risk of bleeding in the low
(RR¼1.16,95%CI 0.63-2.13;P¼0.64) risk stratiﬁcation, but under-pre-
dicts the risk of bleeding in the moderate (RR¼0.66,95%CI 0.51-
0.86;P¼0.002) and high (RR¼0.88,95%CI 0.70-1.10; P¼0.27) risk
stratiﬁcations. There are no signiﬁcant differences between the pre-
dicted and the observed major bleeding events in the low and high
risk stratiﬁcations. With regard to the occurrence of major bleeding
events individually, patients with HAS-BLED scores 3 have a greater
risk of major bleeding(RR¼2.97,95%CI, 2.32–3.80;P<0.00001) than
patients with HAS-BLED scores <3. A chi-squared test for trend showsan increasing trend in the occurrence of major bleeding events across
three risk stratiﬁcations according to the HAS-BLED score(c2¼108.57,
Ptrend<0.001).
CONCLUSIONS The HAS-BLED score not only performs better than
the HEMORR2HAGES and ATRIA bleeding scores, but also is superior
to the CHADS2and CHA2DS2-VASc stroke scores for bleeding predic-
tion. The HAS-BLED score should be the optimal choice to assess
major bleeding risk in clinical practice.
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OBJECTIVES An elevated left atrial pressure (LAP), a sign of atrial
structural remodeling, has been reported as a mechanism of atrial
ﬁbrillation (AF). However, the effect of LAP on the recurrence after AF
catheter ablation has not been well elucidated. We aimed to address
the predictive value of LAP and observe the inﬂuence for prognosis.
METHODS 150 patients of AF who underwent a ﬁrst-time catheter
ablation in our hospital were enrolled in the present study. Including
paroxysmal AF (n¼66) and persistent AF (n¼84). All patients under-
went transseptal puncture during procedure. LAP were measured
during sinus rhythm. According to the values of LAP, the patients
were divided into each two groups, high LAP ofparoxysmal AF group
(HP-PAF) and low LAP of paroxysmal AF group (LP-PAF), high LAP of
persistent AF group (HP-PeAF) and low LAP of persistent AF group
(LP-PeAF). The relationship between LAP and clinical variables were
analyzed. Recurrence rates of the each two groups were evaluated
through follow-up. Cox-regression analysis was implemented to ﬁnd
out the independent determinants of AF/AT recurrence after FRCA.
RESULTS (1) 150 AF patients were successfully followed up in the
study. Following up (10.24.9) months, 17 patients (51.5%) in HP-PAF
group and 29 patients (87.9%) in LP-PAF group maintained sinus after
RFCA (P<0.01). 15 patients (33.3%) in HP-PeAF group and 33 patients
(84.6%) in LP-PeAF group maintained sinus rhythm after RFCA
(P<0.01).
(2) For paroxysmal AF, LVEF (linear regression coefﬁcient B¼-0.761,
P¼0.002) was a good noninvasive parameter independently associ-
ated with LAP. For persistent AF, duration of AF(B¼0.826, P<0.001),
CHADS2-VASc score(B¼2.327, P<0.001), LAVI(B¼0.424, P<0.001 ),
IVS(B¼2.847, P<0.001), E/e’ (B¼-3.330, P<0.001), LVEF(B¼-0.651,
P<0.001) were good noninvasive parameters independently associ-
ated with LAP-PeAF.
(3) For paroxysmal AF, Cox-regression analysis revealed that LAP
(OR 1.27; 95%CI: 1.11-1.45; P<0.01) was the independent predictor of
AF/AT recurrence after FRCA. The area under ROC curve of LAP was
0.626. The cutoff point was 16.75mmHg (sensitivity 76.2%, speciﬁcity
82.2%). For persistent AF, LAP (OR 1.56;95%CI: 1.11-1.82; P¼0.019) was
also the independent predictor of AF/AT recurrence after FRCA. The
area under ROC curve of LAP was 0.836. The cutoff points were
17.3mmHg (sensitivity 83.3%, speciﬁcity 88.9%). In addition, duration
of AF, the antero-posterioratrial diameter of left atrium and LVEF
were also the independent predictors of AF/AT recurrence after FRCA.
And the predictive value of LAP was higher than that of others.
CONCLUSIONS (1) Elevated LAP was closely associated with
anatomical remodeling of the left atrium and was an independent
predictor for clinical recurrence after AF ablation.
(2) For paroxysmal AF, LVEF was a good noninvasive parameter
independently associated with LAP. For persistent AF, duration of AF,
CHADS2-VASc score, LAVI, IVS E/e’, LVEF were good noninvasive
parameters independently associated with LAP-PeAF.
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OBJECTIVES We will analyze the coronary venous system anatomy
through coronary vein direct enhancement and inverse develop-
ment. The conclusion will be used to conﬁrm electrophysiological
examination, radio frequency ablation, implantation of a LV lead and
so on.
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system about 200 patient who had normal heart before. Patients
whose cardiac chamber were normal undergoing coronary angiogra-
phy(CAG) and whose cardiac chamber enlarged were scheduled to
undergo CRT and CAG from 2012-1-1 to 2014-12-31 were enrolled in this
study. All the images would be gathered in the position of RAO 30,
LAO 45 and AP. We used coronary vein direct enhancement for CAG
patients and inverse development for CRT patients.
RESULTS 1 In normal heart group and dilated heart group, the num-
ber of the patients whose CS were tubular-shaped was 16(53.3%) &
18(66.7%), bell-shaped was 14(46.7%) & 9(33.3%). There was no sig-
niﬁcance (P¼0.306).
2 The position of the coronary sinus Horizontal Line: In normal
heart group: there were 7 patients’ CSO 3 centrums below the bifur-
cation tracheae(23.3%); 17 patients’ CSO 3.5 centrums below(56.7%); 5
patients’ CSO 4 centrums below(16.7%); 1 patient’s CSO 4.5 centrums
below(3.3%). In the other group: the numbers were 3(11.1%),
13(48.1%), 10(37.0%), 1(3.8%). There was no signiﬁcance(P¼0.075).
Mid-line: In normal heart group: there were 17(56.7%) patients’ CSO
at the left side of spine, 10(33.3%) in the middle, 3(10.0%) patients at
the right. In another group, the numbers were 11(40.7%), 10(37.0%),
6(22.3%). There was no signiﬁcance(P¼0.164).
3 In normal heart group and dilated heart group, there were
18(60.0%) & 21(77.8%) patients on bottom right, the mean angle was
71.4810.47(52.5w83.1) & 56.61 14.30(30.5w79.1); 2(6.7%) & 1
(4%) patients were on right level, the mean angle was
90.151.48(89.1w91.2) & 90; 10(33.3%) & 5 (18.2%) patients were
on top right, mean angle was 108.5710.16 (96.5w132.8) &
115.7116.77(98.0w142.0). There was no signiﬁcance(P¼0.157).
4 The mean diameter of coronary vein sinus of normal heart group
and dilated heart group: CSO 8.391.62mm & 13.014.77mm, CS-MCV
7.011.88mm & 11.245.25mm, CS-LPV 5.151.63mm & 6.683.02mm,
GCV 3.570.99mm & 4.82 1.62mm, MCV 3.371.09mm &
5.711.47mm, LPV 2.621.80mm & 3.722.55mm. Above all, there was
signiﬁcance between two groups(P<0.05).
5 We divided dilated heart group into two subgroups by sex. The
mean diameter: CSO M 13.315.04mm & F 11.943.83mm. CS-MCV M
11.465.71mm & F 10.373.03mm. CS-LPV M 6.353.05mm & F
7.812.89mm. GCV M 4.791.54mm & F 4.942.05mm. MCV M
5.811.43mm & F 5.311.77mm. LPV M 3.882.81mm & F
3.171.29mm. Above all, there was no signiﬁcant (P>0.05).
CONCLUSIONS 1 Through the comparison between two groups, we
could draw the conclusion that there was no difference in the shape of
the CSO, the position and the angle of the CSO, the diameter of cor-
onary vein system of dilated heart is greater than that of the normal
heart.
2 There was no difference between the groups divided by sex.GW26-e4369
The effectiveness of ibutilide and the factors that affect the successful
cardioversion and ibutilide-induced malignant arrhythmia
Xiaoying Chen, Yanzong Yang, Lianjun Gao, Dong Chang,
Xiaomeng Yin, Yingxue Dong, Xiaohong Yu, Xianjie Xiao,
Shulong Zhang
Arrhythmia Department of First Afﬁliated Hospital of Dalian Medical
University, Dalian Liaoning
OBJECTIVES To determine the effectiveness of ibutilide and the
factors that affect the effectiveness of ibutilide and the factors that
affect the ibutilide-induced malignant arrhythmia.
METHODS Retrospectively collected 155 hopital records of whom use
ibutilide for conversion of atrial ﬂutter and atrial ﬁbrillation <90days’
duration. All data were processed by SPSS, mono factor analyses of
variance and Logistic regression analyses were used to analysis.
RESULTS The total successful conversion ratio of ibutilide is 50.9%.
The cardioversion ratio of atrial ﬂutter is 61% while the cardioversion
ratio of atrial ﬁbrillation is 44%. All failed patients receive biphasic
shock deﬁbrillation return to sinus rhythm. The result of mono factor
analysis of variance shows that weight, LAD, LVD, beta blockers sig-
niﬁcant affect the conversion ratio. Meanwhile the result of Logistic
regression analyses is that lower weight is the predictive factor of
successful conversion. About the safety of ibutilide, 16 patients
develop malignant arrhythmia after using the ibutilide, the ratio is
10.3%. The incidence of drug-induced malignant arrhythmia in atrial
ﬂutter and atrial ﬁbrillation patients is 12.9%and 10.3% respectively.
Mono factor analysis of variance show that the propafenone and
amiodarone inﬂuence the drug-induced arrhythmia. However, by
logstic regression analysis, no factor was found.CONCLUSIONS 1 Ibutilide is an effective and safe drug for conversion
of atrial ﬂutter and atrial ﬁbrillation <90days’ duration.
2 Ibutilide pretreatment preceding biphasic shock deﬁbrillation im-
proves the efﬁcacy of cardioversion.
3 Lower weight is the predictive factor of successful conversion.
4 No predictive factor was found of the ibutilide-induced malignant
arrhythmia.
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OBJECTIVES Torsades de Pointes (TdP) is the cause of SCD in Long
QT syndrome. It is also observed in complete heart block as originally
denominated and described by Dessertenne in 1966. Its mechanism
was considered as the result of two foci with opposite direction and
different rates. This phenomenon has been reproduced in the labo-
ratory. Here we demonstrate by two independent methods that a
reentrant phenomenon and not ectopic foci is the mechanism of TdP
in patients with complete AV block.
METHODS ECG strips were selected from several hours of tape re-
cordings from 2 patients with 39 short lasting episodes of TdP (1.9 
0.7 seconds). The almost same morphology of the initial TdP beats can
be identiﬁed and classiﬁed in different subgroups. In 9 patients’
endocardial recordings (EGM) from regular USCI bipolar catheters
positioned at the apex of the right ventricle were synchronously
recorded with ECG lead II.
RESULTS Patient 1: Three subgroups (a-c) of similar initial beats of TdP
can be identiﬁed. Subgroup (a): 3-5 QRS complexes occurred after a
long QT interval of 600ms. Subgroup (b): 3-13 QRS complexes occurred
with a QT interval of 560ms. Subgroup (c): 4-17 QRS complexes of a
different morphology occurred after the same QT interval of 560ms.
One episode of this group leads to ventricular ﬁbrillation needing DC
shock. The end of 11 episodes out of 15 were announced by an increase
in the amplitude of the QRS complexes. In 4 tracings the initial QRS
complexes with the longest QT (660ms) was followed by identical large
amplitude PVC but a possible start of TdP was aborted. Patient 2: A
constant coupling of 600ms precedes the TdP made of 2-6 consecutive
almost identical QRS complexes. Final increase of amplitude was
observed on 7 out of 13 tracings. Endocardial signals recorded in 5 out
of 9 patients’ EGM showed at the beginning or inside the T wave EGMs
with a coupling interval (160-180ms) preceding fragmentation.
CONCLUSIONS Predetermined variable initial conditions of long QT
initiated by bradycardia in complete AV block demonstrate speciﬁc
preferential pathways of activations during the start of short lasting
episodes of TdP. Immediate reactivation of endocardial potentials
before the end of refractory period suggest that TdP is the result of
slow conduction leading to a large unstable reentrant phenomenon.
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OBJECTIVES To explore the short period inﬂuence factors on cardiac
pacemaker short-term threshold by active ﬁxed pacing leads after
implantation and the myocardial damage. Instantly pacing threshold
and active ﬁxed pacing lead 5-10 minutes after implantation of
pacemaker threshold is deﬁned as short-term pacing threshold.
Evaluation inﬂuence of cardiac pacemaker installation intraoperative
patient general condition and past medical history on short-term
pacing threshold.
METHODS Selected 192 patients with cardiac pacemaker therapy, 136
patients with single active pacing lead used in it, the application of 56
patients with two active pacing leads. All patients who were once
implanted active pacing leads is successful. Using multiariable Lo-
gistic regression analysis of cardiac pacemaker active pacing lead
patients after general situation and past medical history effects on
short-term pacemaker threshold. In a pacemaker preoperative and
postoperative 24 h, 48 h, or even 72 h monitoring concentration of
myocardial enzymes and record. The myocardial enzyme levels in
different time and the comparison between the two groups using
repeated measures design analysis of variance.
